↓ Skip to main content

Dove Medical Press

Resveratrol Ameliorates Systemic Sclerosis via Suppression of Fibrosis and Inflammation Through Activation of SIRT1/mTOR Signaling

Overview of attention for article published in Drug Design, Development and Therapy, December 2020
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
10 Mendeley
Title
Resveratrol Ameliorates Systemic Sclerosis via Suppression of Fibrosis and Inflammation Through Activation of SIRT1/mTOR Signaling
Published in
Drug Design, Development and Therapy, December 2020
DOI 10.2147/dddt.s281209
Pubmed ID
Authors

Qicen Yao, Qingchao Wu, Xiayu Xu, Yixi Xing, Jin Liang, Qianqi Lin, Meiqiong Huang, Yiling Chen, Bo Lin, Weifei Chen

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 3 30%
Student > Ph. D. Student 2 20%
Lecturer 1 10%
Unspecified 1 10%
Unknown 3 30%
Readers by discipline Count As %
Unspecified 1 10%
Pharmacology, Toxicology and Pharmaceutical Science 1 10%
Biochemistry, Genetics and Molecular Biology 1 10%
Nursing and Health Professions 1 10%
Immunology and Microbiology 1 10%
Other 1 10%
Unknown 4 40%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 July 2022.
All research outputs
#22,771,990
of 25,387,668 outputs
Outputs from Drug Design, Development and Therapy
#1,755
of 2,269 outputs
Outputs of similar age
#447,852
of 518,694 outputs
Outputs of similar age from Drug Design, Development and Therapy
#25
of 35 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,269 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 518,694 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 35 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.